Clinical trials

3

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

Neurocognition in Patients With Multiple Brain Metastases Treated With Radiosurgery

This phase II trial studies the neurological function in patients with multiple brain metastases undergoing stereotactic radiosurgery (SRS) or stereotactic body radiation therapy (SBRT). Stereotactic body radiation therapy uses special equipment to position a patient and deliver radiation to tumors with high precision. This method can kill tumor cells with fewer doses over a shorter period and cause less damage to normal tissue. Assessment of neurocognitive function may help show that SRS preserves neurological function in patients with multiple brain metastases better than SBRT.

Participants needed: 90
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityUpdated: May 22, 2026Locations: 2
Eligibility criteria

Pathologically proven solid tumor malignancy (except for small cell lung cancer... [+8]

Patient with diagnosis of glioma, or other World Health Organization (WHO) grade... [+5]

Status: Recruiting

Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI) Cancer Patients: A SMART Pilot Study

The objective of the proposed pilot is to test the feasibility, acceptability, and preliminary efficacy of a 16-week sequential, multiple assessment randomized trial (SMART), which includes virtual Tai Chi/Qi Gong or α- Lipoic acid (ALA) supplements as an initial treatment, and acupuncture as the additional treatment, that examines a stepped-care intervention to address CIPN.

Participants needed: 60
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityUpdated: Apr 14, 2026Locations: 1
Eligibility criteria

Age 18 years or older, [+4]

Prognosis of ≤ 3 months, [+6]

Status: Recruiting

Leveraging Lung Cancer Screening to Optimize Screening Outcomes and COPD Management: COPD in LCS Registry

The COPD in LCS Registry will identify and characterize individuals who have functional or radiographic evidence of COPD and are receiving lung cancer screening. Clinical information will be obtained from study participants including symptom burden, lung cancer risk, spirometry, imaging characteristics, and peripheral blood eosinophils.

Participants needed: 420
Trial details
Age: 50-80Biological sex: AllType: ObservationalSponsor: Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityUpdated: Mar 3, 2026Locations: 1Duration: 12 Months
Eligibility criteria

• * Eligible for lung cancer screening by USPSTF 2021 criteria including age 50-... [+5]

Current (i.e. at the time of the visit) GINA Step 4 or higher therapy (medium do... [+12]